Last reviewed · How we verify
Cartonic — Competitive Intelligence Brief
marketed
amrinone
cGMP-inhibited 3',5'-cyclic phosphodiesterase A
Cardiovascular
Live · refreshed every 30 min
Target snapshot
Cartonic (amrinone) — Sanofi.
Comparator set (3 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cartonic TARGET | amrinone | Sanofi | marketed | amrinone | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 1984-01-01 |
| Pletal | CILOSTAZOL | Otsuka | marketed | Phosphodiesterase 3 Inhibitor [EPC] | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 1999-01-01 |
| Agrylin | ANAGRELIDE | Takeda | marketed | Platelet-reducing Agent | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 1997-01-01 |
| Pletal | Pletal | Otsuka America Pharmaceutical | marketed | Cytochrome P450 2C9, cGMP-inhibited 3',5'-cyclic phosphodiesterase A, cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (amrinone class)
- Sanofi · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cartonic CI watch — RSS
- Cartonic CI watch — Atom
- Cartonic CI watch — JSON
- Cartonic alone — RSS
- Whole amrinone class — RSS
Cite this brief
Drug Landscape (2026). Cartonic — Competitive Intelligence Brief. https://druglandscape.com/ci/amrinone. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing